Dr KOLODYCH Sergii
Fiche personne
coordonnées
Syndivia
650 Boulevard Gonthier d’Andernach
67400 ILLKIRCH
+33 3 68 85 43 01
Territoire
Alsace
Statut
Chercheur
équipes/plateformes
Recherche
Mots clés : Targeted cancer therapies,Antibody-Drug Conjugates
Publications
INA03, a potent transferrin-competitive antibody-drug conjugate against CD71, for a safer acute leukemia treatment.
Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, Marchal M, Castellano R, Josselin E, Pasquer H, Benajiba L, Puissant A, Koniev O, Collette Y, Belanger C, Hermine O, Monteiro RC, Launay P
Mol Cancer Ther. 2024 04 20;:
Reinvestigation of the Automated Synthesis of Stoichiometrically Conjugated Antibodies to Access High Molecular Weight Payloads and Multiplexed Conjugation via an In-Solution Trans-Tagging Process.
Lehot V, Lidický O, Most J, Erb S, Dovgan I, Osypenko A, Koniev O, Kolodych S, Kotrchová L, Chaubet G, Cianférani S, Etrych T, Wagner A
ACS Omega. 2023 10 31;8(43):40508-40516
Thermofluorimetric Analysis (TFA) using Probes with Flexible Spacers: Application to Direct Antibody Sensing and to Antibody-Oligonucleotide (AbO) Conjugate Valency Monitoring.
Kurian ASN, Gurukandure A, Dovgan I, Kolodych S, Easley CJ
Anal Chem. 2023 07 25;: